Literature DB >> 1002007

Combined administration of low dose heparin and aspirin as prophylaxis of deep vein thrombosis after hip joint surgery.

T H Schöndorf, D Hey.   

Abstract

The study was carried out on 75 patients undergoing hip joint surgery. The efficacy of a prophylaxis of deep vein thrombosis (DVT) by acetylsalicyclic lysine (ASL) and by a low dose heparin (LDH) combined with the ASL treatment was investigated using the 125I-fibrinogen test. DVT was not significantly decreased by the ASL application (53%) compared to the controls (60%). DVT occurred significantly less under the combined administration (27%) than in the other two groups.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1002007     DOI： 10.1159/000214140

Source DB:  PubMed          Journal:  Haemostasis        ISSN： 0301-0147


  6 in total

Review 1.  Antiplatelet treatment for thromboprophylaxis: a step forward or backwards?

Authors:  A T Cohen; J A Skinner; V V Kakkar
Journal:  BMJ       Date:  1994-11-05

Review 2.  Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.

Authors:  R Collins; C Baigent; P Sandercock; R Peto
Journal:  BMJ       Date:  1994-11-05

3.  Failure of aspirin to prevent postoperative deep vein thrombosis in patients undergoing total hip replacement.

Authors:  J D Stamatakis; V V Kakkar; D Lawrence; P G Bentley; D Nairn; V Ward
Journal:  Br Med J       Date:  1978-04-22

4.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

Review 5.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

6.  [Clinical and in-vitro studies of the therapeutical range of acetylsalicylic-acid to prevent deep vein thrombosis (author's transl)].

Authors:  T H Schöndorf; D Hey; H G Lasch
Journal:  Klin Wochenschr       Date:  1978-11-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.